Skip to content

GS PHARMA

Active Private limited companyfounded 2012active for 14 yearsBrusselstraat 5, 1702 DilbeekKBO/BCE: BE 0848.422.277 subsidiary of

Board

1 director, since incorporation
Manager, permanent representative
appointed by deed of 06-09-2012 term without a fixed end
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 20-06-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 24-05-2023
Permanent representatives 1
Permanent representative, for
appointed by deed of 06-09-2012

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Manager
Board
Mandates as a list
    • Manager, appointed by deed of 06-09-2012, still in office

Control

Parent
Equity €1.8m
Profit €34,066 in 2024 (profit €41,833 in 2023)
Source: accounts 31-03-2024
100%
This company
GS PHARMA
Equity €148,356
Profit €124,005 in 2025

Capital

Contribution
€20,000
Shares
1,000
Contribution per share
€20
Equity per share
€148 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
100%
Owners as a list
    • 2013 to 2019: 60%
    • 2020 to 2024: 100%

Source: lists of holdings in the owners' accounts

Articles of association

deed of 24-05-2023 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of May at 20:00

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 24-05-2023 ↗
  • all shares
At incorporation deed of 06-09-2012 ↗
  • 300 shares (30%) · €6,000
  • 700 shares (70%) · €14,000
Capital over time
  1. 24-05-2023 Converted to unavailable equity
  2. 06-09-2012 Incorporation · €20,000 · 1,000 shares

Next steps